RCA
LH icon

Resonant Capital Advisors’s Labcorp LH Stock Holding History

Resonant Capital Advisors’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$977K Sell
3,491
-593
-15% -$156K 0.05% 186
2026
Q1 		$1.09M Buy
4,084
+311
+8% +$84.2K 0.06% 169
2025
Q4 		$947K Buy
3,773
+138
+4% +$36.7K 0.05% 168
2025
Q3 		$1.04M Buy
3,635
+8
+0.2% +$2.14K 0.06% 164
2025
Q2 		$952K Buy
3,627
+134
+4% +$32.6K 0.06% 164
2025
Q1 		$813K Buy
3,493
+51
+1% +$12.4K 0.06% 162
2024
Q4 		$789K Buy
3,442
+34
+1% +$7.8K 0.06% 167
2024
Q3 		$762K Buy
3,408
+36
+1% +$7.91K 0.06% 173
2024
Q2 		$686K Buy
3,372
+320
+10% +$65.1K 0.06% 172
2024
Q1 		$667K Buy
3,052
+33
+1% +$7.27K 0.06% 173
2023
Q4 		$686K Sell
3,019
-190
-6% -$39.9K 0.07% 164
2023
Q3 		$645K Sell
3,209
-326
-9% -$68.8K 0.07% 153
2023
Q2 		$733K Buy
3,535
+74
+2% +$14.4K 0.08% 143
2023
Q1 		$682K Buy
3,461
+89
+3% +$18.3K 0.08% 144
2022
Q4 		$682K Sell
3,372
-12
-0.4% -$2.35K 0.09% 140
2022
Q3 		$595K Buy
3,384
+56
+2% +$11.5K 0.09% 134
2022
Q2 		$670K Buy
3,328
+110
+3% +$23.4K 0.1% 126
2022
Q1 		$728K Buy
3,218
+179
+6% +$42.1K 0.11% 116
2021
Q4 		$820K Buy
3,039
+71
+2% +$17.6K 0.12% 97
2021
Q3 		$718K Buy
2,968
+561
+23% +$141K 0.12% 99
2021
Q2 		$570K Buy
2,407
+14
+0.6% +$3.19K 0.11% 102
2021
Q1 		$524K Buy
2,393
+9
+0.4% +$1.81K 0.11% 99
2020
Q4 		$417K Buy
2,384
+110
+5% +$19K 0.1% 117
2020
Q3 		$368K Sell
2,274
-481
-17% -$76.2K 0.1% 114
2020
Q2 		$393K Sell
2,755
-1,854
-40% -$257K 0.11% 122
2020
Q1 		$501K Buy
4,609
+337
+8% +$48.6K 0.18% 126
2019
Q4 		$621K Buy
+4,272
New +$617K 0.2% 127

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Resonant Capital Advisors's LH Position: Q2 2026 in Review

Resonant Capital Advisors reduced its Labcorp (LH) stake by 15% in Q2 2026, selling an estimated $156K and leaving 3,491 shares worth $977K. The position accounts for 0.05% of the portfolio, ranked #186.

Resonant Capital Advisors first reported a position in LH in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.09M in Q1 2026. 1,059 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Resonant Capital Advisors held 3,491 shares of Labcorp worth $977K as of Q2 2026.
  • Resonant Capital Advisors sold 593 Labcorp shares in Q2 2026, an estimated $156K.
  • Labcorp made up 0.05% of Resonant Capital Advisors's portfolio in Q2 2026, its #186 holding.
  • Resonant Capital Advisors first reported a position in Labcorp in Q4 2019 and has held it in 27 quarters since.
  • Resonant Capital Advisors's Labcorp position peaked at $1.09M in Q1 2026.
  • 1,059 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Resonant Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.